Me and the world of investing. But hey, buy some more cheapies. Plenty of world renowned oncologists, including Stupp, have questioned the trial.
Now ask yourself who has more trial experience as a principal investigator in getting a GBM treatment approved with the FDA. Stupp or all those who signed off on the JAMA paper combined so they could pad their publication status?
Once again Icy claims to be more knowledgeable than the world renowned JAMA.
JAMA has published many papers on successful trials that did not yield an FDA approval. That is not their charter to evaluate if results are suitable for approval.
Further, the paper states clearly under limitations a huge issue with it being suitable for approval. Why is it you disagree with that flag raised by the paper itself, and noted by LP as a serious problem?
Market Data 
Markets 
AI
